Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Glycogen storage myopathies.

S Tsujino1, I Nonaka, S DiMauro

  • 1Section Chief, Department of Inherited Metabolic Disease, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan.

Neurologic Clinics
|February 5, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enhanced immunity in intradermal vaccination by novel hollow microneedles.

Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)·2018
Same author

Cloning and mapping of a very short (10-kb) EcoRI fragment associated with facioscapulohumeral muscular dystrophy (FSHD).

Muscle & nerve. Supplement·2013
Same author

Inflammatory response in facioscapulohumeral muscular dystrophy (FSHD): immunocytochemical and genetic analyses.

Muscle & nerve. Supplement·2013
Same author

Characterization of the Asian myopathy patients with VCP mutations.

European journal of neurology·2011
Same author

Difference in the nature of tannins on in vitro ruminal methane and volatile fatty acid production and on methanogenic archaea and protozoal populations.

Journal of dairy science·2009
Same author

Novel FHL1 mutations in fatal and benign reducing body myopathy.

Neurology·2009
Same journal

Sports Neurology.

Neurologic clinics·2026
Same journal

Sports-Related Peripheral Nerve Injuries.

Neurologic clinics·2026
Same journal

Active Rehabilitation and Return to Play in Sports-Related Concussion.

Neurologic clinics·2026
Same journal

Autonomic Assessment and Management in Sports-Related Concussion.

Neurologic clinics·2026
Same journal

Management of Vestibular Symptoms in Sports-Related Concussion.

Neurologic clinics·2026
Same journal

Neuropsychological Assessment in Sport-Related Concussion: Evidence, Controversies, and Clinical Applications.

Neurologic clinics·2026
See all related articles

Glycogen storage myopathies result from enzyme defects affecting energy pathways in muscles. Recent genetic discoveries offer insights, but linking specific gene defects to symptoms remains challenging.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Genetics

Background:

  • Glycogen storage myopathies (GSMs) are a group of inherited metabolic disorders.
  • These conditions arise from enzyme deficiencies within the glycogenolytic or glycolytic pathways.
  • Affected tissues primarily include skeletal muscle, but can involve other organs.

Purpose of the Study:

  • To review recent advancements in the understanding of glycogen storage myopathies.
  • To highlight new findings, such as aldolase deficiency.
  • To discuss the growing body of molecular genetic data in GSMs.

Main Methods:

  • Literature review of recent findings in glycogen storage myopathies.
  • Analysis of accumulating molecular genetic data.

Related Experiment Videos

  • Examination of genotype-phenotype correlations.

    • Main Results:

    • Recent research has identified new entities like aldolase deficiency.
    • Significant progress has been made in accumulating molecular genetic data for GSMs.
    • Despite advances, clear genotype-phenotype correlations are still lacking for most GSMs.

    Conclusions:

    • The field of glycogen storage myopathies is rapidly evolving with new discoveries.
    • Molecular genetics is providing deeper insights into the molecular basis of GSMs.
    • Further research is needed to establish robust genotype-phenotype correlations for improved clinical management.